SEC Filing Analysis: REVVITY, INC. (RVTY)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: Revvity issued a positive pre-announcement, raising its full-year 2025 adjusted EPS guidance above the prior range of $4.90-$5.00, signaling operational outperformance.
• Market Impact: The update is a moderately bullish signal ahead of a major industry conference. It suggests operational strength and could lead to positive analyst revisions.

Filing & Company Information

Field	Value
Company	REVVITY, INC.
Ticker Symbol	RVTY
CIK	0000031791
Market Cap	$10.51 billion
Form Type	8-K
Event Date	2026-01-12

Key Financial Updates

This Form 8-K announces preliminary financial results and updated guidance.

Metric	Value	Note
FY 2025 Revenue	~$2.86 billion	Approx. 3% organic growth
Q4 2025 Revenue	~$772 million	Approx. 4% organic growth
FY 2025 Adj. EPS	> $5.00	Exceeds previous guidance of $4.90-$5.00
2026 Outlook	2-3% organic growth	HSD (High-Single-Digit) adj. EPS growth expected

Financial Impact Assessment

Impact Evaluation

• Guidance Beat: Raising guidance, even before final results, is a strong signal of management's confidence and the company's performance. For a large-cap company like Revvity, this indicates solid execution.
• Capital Allocation: The filing's associated presentation highlights ~$1.4 billion in share repurchases since 2023, reducing the share count by ~10%. This is a significant return of capital to shareholders and is accretive to EPS.
• Profitability Focus: While the 2026 organic growth forecast of 2-3% is modest, the company is guiding for high-single-digit adjusted EPS growth, indicating a strong focus on margin expansion and operational efficiency, with a stated goal of 28.0% adjusted operating margins in 2026.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral with a Positive bias
• Reasoning: An upward revision to EPS guidance is fundamentally positive. However, the market reaction will depend on how this compares to analyst 'whisper numbers' and the full details to be provided on the subsequent earnings call. The modest 2026 growth outlook may temper excitement.

Volume & Sentiment

• Expected Volume Impact: A near-term increase in trading volume is likely, particularly around the J.P. Morgan conference presentation.
• Sentiment Indicator: Bullish. The company is proactively communicating positive news and demonstrating financial discipline through buybacks and margin improvement initiatives.

Investment Insights

Positive Market Indicators

• Earnings Outperformance: The company is set to beat its full-year 2025 adjusted EPS guidance.
• Shareholder Returns: Aggressive share repurchase program has significantly reduced shares outstanding, boosting per-share metrics.
• Margin Expansion: A clear strategy is in place to improve profitability, even with modest top-line growth.

Risk Factors

• Modest Growth Outlook: The 2026 organic growth forecast of 2-3% is below the company's long-range plan of 6-8%, suggesting potential near-term market headwinds or conservatism.
• Non-GAAP Focus: The positive EPS news is for adjusted EPS. Investors will need to scrutinize the GAAP reconciliation when full results are released.

Key Takeaways

1. Operational Strength: Revvity is executing well, leading to better-than-expected profitability for 2025.
2. Disciplined Capital Use: The company is actively returning capital to shareholders through buybacks, enhancing shareholder value.
3. Strategic Communication: The announcement is timed to build positive momentum ahead of a key investor conference, showcasing recent successes and future strategy.

Additional Context

Transaction Notes

• Timing: The announcement was made on January 12, 2026, the day before a scheduled presentation at the 44th Annual J.P. Morgan Healthcare Conference.
• Nature of Data: All announced financial figures are preliminary and subject to completion of the company's year-end closing procedures.